Close

Anti-CDH1 DNA-encoded mAb (DMAb), pVAX1 (DMAb-2784-FY)


All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

This product is the plasmid containing an encoded anti-CDH1 DMAb sequence. The plasmid can drive transcription and in vivo translation of the desired antibody.

  Add to Cart

Specifications

  • Target
  • CDH1
  • Vector Name
  • pVAX1
  • Vector Description
  • pVAX1 was originally designed for the development of DNA vaccines. Its eukaryotic DNA sequences limited to the expression of desired sequence so that minimize the possibility of chromosomal integration. This vector has been widely used for the construction of DMAb plasmid.
  • Vector Promoter
  • CMV
  • Vector Tag or Fusion
  • Untagged
  • Delivery Method
  • Transfection
  • Cloning Method
  • Restriction Enzyme ⁄ MCS
  • Constitutive or Inducible System
  • Constitutive
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term.
  • Background
  • DNA-encoded mAb (DMAb) technology is a novel approach for a direct in vivo production of desired biologically active immunoglobulins according to the plasmid DNA delivery into tissue where the delivered plasmid containing an encoded antibody sequence. Compared with the traditional mAb, DMAb can be functionally equivalent with additional advantages such as expression profiles, glycosylation, as well as no reliance on in vivo tissue culture and costly or time-consuming production systems. The DMAb technology may provide a novel, simple, less frequent, cost-effective approach for therapeutics.

Target

  • Entrez Gene ID
  • 999
Sub CAT. DMAb Clone DMAb Host Target Species DMAb Isotype DMAb Immunogen  
DMAb-0014-FY 24E10 Rabbit IgG
DMAb-0015-FY 67A4 Mouse IgG1
DMAb-0016-FY 967717 Mouse Human IgG2a Human embryonic kidney cell line HEK293-derived transfected with human E-Cadherin
DMAb-0017-FY AR38.2 Mouse IgG1 Recombinant Fizzy Related Protein
DMAb-0018-FY CDH1/1121 Mouse Human IgG1, κ Recombinant fragment of human E-Cadherin protein
DMAb-0019-FY CDH1/1525 Mouse Human IgG1, κ Recombinant human full-length E-Cadherin protein
DMAb-0020-FY CL1172 Mouse Human IgG1 This antibody was developed against a recombinant protein corresponding to amino acids: ATDNGSPVATGTGTLLLILSDVNDNAPIPEPRTIFFCERNPKPQVINIIDADLPPNTSPFTAELTHGASANWTIQYNDPTQESIILKPKMALEVGDYKINLKLMDNQNKDQVTTLEVSVCDCEGA
DMAb-0021-FY DECMA-1 Rat IgG1
DMAb-0022-FY ECCD-1 Rat Mouse IgG2b Mouse teratocarcinoma cell line F9
DMAb-0023-FY ECCD-2 Rat Mouse IgG2a Mouse liver E-cadherin fragment
DMAb-0024-FY EP700Y Rabbit Human IgG
DMAb-0025-FY HECD-1 Mouse Human IgG1 Human breast tumor cell line MCF-7
DMAb-0026-FY NCH-38 Mouse IgG1, κ E-cadherin and GST recombinant protein
DMAb-0027-FY SHE78-7 Mouse Human IgG2a Soluble E-cadherin from human placenta
DMAb-0028-FY SPM381 Mouse Human IgG1, κ Recombinant human full-length E-Cadherin protein
DMAb-0360-CQ CDH1/1122 Mouse Human IgG1, κ
DMAb-0361-CQ DH01 Mouse Human IgG1, κ
DMAb-0367-CQ 813CT11.1.3 Mouse Human IgG1 Purified His-tagged CDH1 protein
DMAb-0369-CQ MB2 Mouse Human IgG2b
DMAb-097-YC GT477 Mouse Human IgG2a Recombinant protein encompassing a sequence within the center region of human E-Cadherin.
DMAb-098-YC GT311 Mouse Human IgG1 Recombinant protein encompassing a sequence within the center region of human E-Cadherin.
DMAb-099-YC GT358 Mouse Human IgG2b Recombinant protein encompassing a sequence within the center region of human E-Cadherin.

Customer Reviews and Q&As

There are currently no customer reviews or questions for Anti-CDH1 DNA-encoded mAb (DMAb), pVAX1 (DMAb-2784-FY). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Related Products

Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.